We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
-13.33%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$463M
AUM Growth
-$145M
Cap. Flow
-$60.8M
Cap. Flow %
-13.14%
Top 10 Hldgs %
40.7%
Holding
140
New
5
Increased
9
Reduced
58
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 23.58%
2 Healthcare 18.17%
3 Financials 18.09%
4 Consumer Discretionary 11.74%
5 Communication Services 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
26
Chevron
CVX
$382B
$6.34M 1.37%
58,297
-10,003
-15% -$1.16M
JPM icon
27
JPMorgan Chase
JPM
$956B
$6.31M 1.36%
64,610
-5,400
-8% -$575K
GOOG icon
28
Alphabet (Google) Class C
GOOG
$4.35T
$6M 1.3%
115,840
-2,700
-2% -$145K
CSCO icon
29
Cisco
CSCO
$483B
$5.94M 1.28%
137,076
-23,200
-14% -$1.06M
CELG
30
DELISTED
Celgene Corp
CELG
$4.91M 1.06%
76,572
-57,201
-43% -$4.22M
SLB icon
31
SLB Ltd
SLB
$78.9B
$4.9M 1.06%
135,741
-73,712
-35% -$3.64M
AMAT icon
32
Applied Materials
AMAT
$415B
$3.23M 0.7%
98,805
AFL icon
33
Aflac
AFL
$61.1B
$3.06M 0.66%
67,086
-4,532
-6% -$201K
PG icon
34
Procter & Gamble
PG
$340B
$2.94M 0.63%
31,955
-7,700
-19% -$688K
REGN icon
35
Regeneron Pharmaceuticals
REGN
$83.2B
$2.13M 0.46%
5,711
-19,949
-78% -$7.3M
VRTX icon
36
Vertex Pharmaceuticals
VRTX
$133B
$1.86M 0.4%
11,202
-125
-1% -$21.7K
HAL icon
37
Halliburton
HAL
$28B
$1.85M 0.4%
69,575
-68,975
-50% -$2.33M
RDS.A
38
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.61M 0.35%
27,574
AGN
39
DELISTED
Allergan plc
AGN
$1.51M 0.33%
11,273
-44,536
-80% -$7.3M
VZ icon
40
Verizon
VZ
$195B
$1.51M 0.33%
26,775
-5,000
-16% -$284K
ABBV icon
41
AbbVie
ABBV
$438B
$1.49M 0.32%
16,145
-8,900
-36% -$783K
WFC.PRL icon
42
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.65B
$1.47M 0.32%
1,165
-525
-31% -$665K
GILD icon
43
Gilead Sciences
GILD
$165B
$1.42M 0.31%
22,705
-8,000
-26% -$559K
BGS icon
44
B&G Foods
BGS
$276M
$1.31M 0.28%
45,200
-17,800
-28% -$509K
DD icon
45
DuPont de Nemours
DD
$19.1B
$1.18M 0.25%
8,687
-227
-3% -$32.6K
XOM icon
46
ExxonMobil
XOM
$657B
$1.12M 0.24%
16,431
-6,264
-28% -$491K
TWO.PRE
47
DELISTED
Two Harbors Investment Corp. 7.50% Series E Cumulative Redeemable Preferred Stock
TWO.PRE
$1.05M 0.23%
45,750
-23,300
-34% -$551K
PFE icon
48
Pfizer
PFE
$154B
$915K 0.2%
22,092
VRSN icon
49
VeriSign
VRSN
$26.5B
$898K 0.19%
6,058
MSFT icon
50
Microsoft
MSFT
$3.76T
$877K 0.19%
8,638
-1,434
-14% -$154K

Similar funds

Kelly Lawrence W & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Kelly Lawrence W & Associates held 140 positions worth $463M, down 24% from $608M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Kelly Lawrence W & Associates withdrew a net $60.8M in Q4 2018, closing 10 positions and reducing 58 holdings. Its most notable exit was Citizens Financial Group, an estimated $11.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Kelly Lawrence W & Associates opened a new position in Energy Transfer Partners worth $96K.

  • Kelly Lawrence W & Associates's largest Q4 2018 buy was Energy Transfer Partners: 7,296 shares worth $96K.
  • Kelly Lawrence W & Associates added most to Home Depot in Q4 2018, an estimated $14.5M increase.
  • Kelly Lawrence W & Associates's biggest Q4 2018 reduction was Regeneron Pharmaceuticals, cutting an estimated $7.3M.
  • Kelly Lawrence W & Associates fully exited Citizens Financial Group in Q4 2018, selling an estimated $11.7M.
  • Kelly Lawrence W & Associates's ten largest holdings make up 41% of its $463M portfolio in Q4 2018.
  • Kelly Lawrence W & Associates opened 5 new positions and closed 10 in Q4 2018.
  • Kelly Lawrence W & Associates's portfolio value fell 24% quarter-over-quarter to $463M.

Based on Kelly Lawrence W & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.